middle.news
Avecho Addresses ASX Price Query Amid Speculation on CBD Trial Milestone
1:11pm on Friday 14th of February, 2025 AEDT
•
Biotechnology
Read Story
Avecho Addresses ASX Price Query Amid Speculation on CBD Trial Milestone
1:11pm on Friday 14th of February, 2025 AEDT
Key Points
Avecho denies any undisclosed material information affecting recent share price
Trading activity possibly driven by speculation on Phase III CBD insomnia trial results
Company confirms compliance with ASX Listing Rule 3.1
Board-authorised response aims to reassure investors amid heightened trading volume
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avecho Biotechnology (ASX:AVE)
OPEN ARTICLE